Opinion: Why the FDA should not approve an ineffective multicancer screening test

In an opinion piece, H. Gilbert Welch argues that the FDA should not approve Grail's multicancer screening test, which he describes as ineffective, writing that “telling more people they have cancer is not progress; progress is having fewer people die from cancer.” This is the author's opinion, not a regulatory decision.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.